Scientific Research News

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, applauds recent comments made by Dr. Martin Makary, Commissioner of the U.S. FDA relating to the importance of accelerating and prioritizing research on the clinical benefits of psychedelic therapeutics. “It is gratifying that th...

CHICAGO--(BUSINESS WIRE)--Xeris Announces Details for Analyst & Investor Day...

LAKE FOREST, Calif. & WOODLAND PARK, N.J.--(BUSINESS WIRE)--Summit Health Announces Internalization of Genomic Testing Cooperative State-of-The-Art Next Generation Sequencing DNA and RNA Profiling Tests...

PHILADELPHIA--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in tissue-targeted AAV gene therapy, today announces the publication of a seminal research manuscript in Nature Communications: “Optimized AAV capsids for basal ganglia diseases show robust potency and distribution.” The study, led by Latus founder Beverly Davidson, Ph.D., details the discovery of a novel adeno-associated virus (AAV) capsid variant - AAV-DB-3 - that is poised to address the long-...

BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, today announced it will present results from the Phase 3 SURPASS-ET clinical trial in an oral session at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30-June 3 in Chic...

PALO ALTO, Calif.--(BUSINESS WIRE)--D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), a leader in quantum computing systems, software, and services, today announced the general availability of its Advantage2TM quantum computing system, a powerful and energy-efficient annealing quantum computer capable of solving computationally complex problems beyond the reach of classical computers. Featuring D-Wave’s most advanced quantum processor to date, the Advantage2 system is commercial-gra...

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR) today announced that the company and Geoffrey Porges, MBBS., have mutually agreed that Dr. Porges will depart from his role as chief financial officer to pursue other opportunities. Richie Jain, who previously served as Schrödinger’s senior vice president, strategic finance and head of corporate and business development, will succeed Geoffrey Porges as chief financial officer. Dr. Porges will serve as an advisor to the company through June 6...

CAMBRIDGE, England--(BUSINESS WIRE)--Shift Bioscience (Shift), a biotech company using an AI powered virtual cell to fight age-driven diseases, today announced the appointments of Lord David Prior as Chair of the Board and Sir Tony Kouzarides as Scientific Advisor. Bringing significant industry expertise and leadership, Tony and David will provide crucial support to advance Shift’s therapeutic pipeline, helping to foster new industry partnerships and broaden awareness of the Company’s long-term...

ROCHDALE, England & TRAMORE, Ireland--(BUSINESS WIRE)--Astoriom expands stability storage capabilities at Tramore site to meet demand for scalable, flexible, regulatory-compliant storage solutions....

ESPOO, Finland--(BUSINESS WIRE)--IQM Quantum Computers, a global leader in superconducting quantum computers, announced today the signing of an agreement with VTT Technical Research Centre in Finland to deliver a 150-qubit and a 300-qubit quantum computer. The systems will be delivered in 2026 and 2027 and integrated with the Finnish HPC infrastructure. The 300-qubit quantum computer is purpose-built and designed to support quantum error correction experiments an essential step toward fault-tol...